16
Jun
2026

Hubei Lingsheng Pharmaceuticals Co., Ltd.

Exhibitor at CPHI & PMEC China 2026 stand W4C60, Pharma Ingredients
About Us

Hubei Lingsheng Pharmaceuticals Co., Ltd. was established on December 29, 2010 and headquarter in Xiangcheng Economic Development Zone, Xiangyang City, Hubei Province with an area of more than 230 mu. We are a professional pharmaceutical enterprise, covering R&D, production, distribution and technical services of a whole industry chain for oral cephalosporin antibiotics, include Key intermediates, APIs and Preparations. The company has two subsidiaries, Lingsheng (Wuhan) Biopharmaceutical Technology Co., Ltd and Hubei Lingsheng Pharmaceuticals Import & Export Co., Ltd. We are equipped with advanced experimental analytical instruments and testing equipments, fully functional workshops, and technologically advanced environmental protection treatment facilities and systems. We plan to be a pharmaceutical center base of oral cephalosporin antibiotics for key intermediates, APIs and Preparations with an annual output of 1000 tons. We are committed to provide safe and high quality products for domestic and international manufacturers and to build the core competition strength for our strategic partners. The core products includes key intermediates, APIs and Preparations of oral cephalosporins : such as 7-AVCA, 7-APRA, 7-ATCA, 7-AMCA, 7-ANCA, 7-ANCE, 7-ACCA, 7-AMOCA, 7-ATFA, ACLE, BCN, CHS, 3-OH, OXAT(short name 10A1B1C2O) and Cefditoren Pivoxil, Cefcapene Pivoxil Hydrochloride, Cefpodoxime proxetil, Ceftibuten.,etc. Products were exported to India, Pakistan, Bangladesh, Iran, Japan, South Korea, Spain, Italy, Oman as well as other countries. After 10 years accumulation, Lingsheng Pharma has been grown into a National High-Tech Enterprise, a Provincial-level Enterprise Technology Center, a National Intellectual Property Advantage Enterprise, an Invisible Champion Enterprise In Provincial Subdivisions, and a National-level Specialized, Fine, Special and New "Little Giant" Enterprise. We are also the production and R&D center of the bioenzymatic cephalosporins, the Chinese Industry-University-Research Cooperation Innovation Achievement Outstanding Enterprise with a number of national and provincial honors.

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    500 - 999
Company types
Pharmaceutical company
Contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand W4C60, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • 7-ACCA

    Product 7-ACCA

    头孢克洛母核(Intermediate of Cefaclor)

  • Cefpodoxime Proxetil

    Product Cefpodoxime Proxetil

    Cefpodoxime Proxetil
  • Cefixime trihydrate

    Product Cefixime trihydrate

    Cefixime trihydrate

  • Ceftibuten Dhydrate

    Product Ceftibuten Dhydrate

    产品名称(Product name):头孢布烯Ceftibuten Dhydrate

  • 7-AVCA

    Product 7-AVCA

    产品名称(Product name):7-AVCA
    头孢克肟、头孢地尼母核(Intermediate of Cefixime&Cefdinir)